APA (7th ed.) Citation

Breunig, C., & Hoffmann, K. (2014). BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma. Clinical cancer research, 20(9), . https://doi.org/10.1158/1078-0432.CCR-13-1635

Chicago Style (17th ed.) Citation

Breunig, Christian, and Katrin Hoffmann. "BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma." Clinical Cancer Research 20, no. 9 (2014). https://doi.org/10.1158/1078-0432.CCR-13-1635.

MLA (9th ed.) Citation

Breunig, Christian, and Katrin Hoffmann. "BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma." Clinical Cancer Research, vol. 20, no. 9, 2014, https://doi.org/10.1158/1078-0432.CCR-13-1635.